Cargando…

A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19)

BACKGROUND: Earlier studies have reported high antibiotic use in patients hospitalised for coronavirus disease 2019 (COVID-19), resulting in concerns of increasing antimicrobial resistance with increase antibiotic use in this pandemic. Point prevalence survey (PPS) can be a quick tool to provide ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Sock Hoon, Ng, Tat Ming, Tay, Hui Lin, Yap, Min Yi, Heng, Shi Thong, Loo, Audrey Yong Xin, Teng, Christine B., Lee, Tau Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722492/
https://www.ncbi.nlm.nih.gov/pubmed/33307276
http://dx.doi.org/10.1016/j.jgar.2020.11.025
_version_ 1783620164599676928
author Tan, Sock Hoon
Ng, Tat Ming
Tay, Hui Lin
Yap, Min Yi
Heng, Shi Thong
Loo, Audrey Yong Xin
Teng, Christine B.
Lee, Tau Hong
author_facet Tan, Sock Hoon
Ng, Tat Ming
Tay, Hui Lin
Yap, Min Yi
Heng, Shi Thong
Loo, Audrey Yong Xin
Teng, Christine B.
Lee, Tau Hong
author_sort Tan, Sock Hoon
collection PubMed
description BACKGROUND: Earlier studies have reported high antibiotic use in patients hospitalised for coronavirus disease 2019 (COVID-19), resulting in concerns of increasing antimicrobial resistance with increase antibiotic use in this pandemic. Point prevalence survey (PPS) can be a quick tool to provide antibiotic prescribing information to aid antimicrobial stewardship (AMS) activities. OBJECTIVES: To describe antibiotic utilization and evaluate antibiotic appropriateness in COVID-19 patients using PPS. METHODS: Adapting Global-PPS on antimicrobial use, the survey was conducted in COVID-19 wards at 2 centres in Singapore on 22 April 2020 at 0800h. Patients on systemic antibiotics were included and evaluated for antibiotic appropriateness. RESULTS: Five hundred and seventy-seven patients were screened. Thirty-six (6.2%) patients were on antibiotics and which were started at median of 7 days (inter-quartile rate (IQR), 4, 11) from symptom onset. Fifty-one antibiotics were prescribed in these patients. Overall, co-amoxiclav (26/51, 51.0%) was the most often prescribed antibiotic. Thirty-one out of 51 (60.8%) antibiotic prescriptions were appropriate. Among 20 inappropriate prescriptions, 18 (90.0%) were initiated in patients with low likelihood of bacterial infections. Antibiotic prescriptions were more appropriate when reviewed by infectious diseases physicians (13/31 [41.9%] versus 2/20 [10.0%], p = 0.015), and if reasons for use were stated in notes (31/31 [100.0%] versus 16/20 [80.0%], p = 0.019). CONCLUSIONS: Despite low prevalence of antibiotic use among confirmed and suspected COVID-19 patients at 2 centres in Singapore, there was significant proportion of inappropriate antibiotics use where bacterial infections were unlikely. AMS teams can tailor stewardship strategies using PPS results.
format Online
Article
Text
id pubmed-7722492
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.
record_format MEDLINE/PubMed
spelling pubmed-77224922020-12-10 A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19) Tan, Sock Hoon Ng, Tat Ming Tay, Hui Lin Yap, Min Yi Heng, Shi Thong Loo, Audrey Yong Xin Teng, Christine B. Lee, Tau Hong J Glob Antimicrob Resist Short Communication BACKGROUND: Earlier studies have reported high antibiotic use in patients hospitalised for coronavirus disease 2019 (COVID-19), resulting in concerns of increasing antimicrobial resistance with increase antibiotic use in this pandemic. Point prevalence survey (PPS) can be a quick tool to provide antibiotic prescribing information to aid antimicrobial stewardship (AMS) activities. OBJECTIVES: To describe antibiotic utilization and evaluate antibiotic appropriateness in COVID-19 patients using PPS. METHODS: Adapting Global-PPS on antimicrobial use, the survey was conducted in COVID-19 wards at 2 centres in Singapore on 22 April 2020 at 0800h. Patients on systemic antibiotics were included and evaluated for antibiotic appropriateness. RESULTS: Five hundred and seventy-seven patients were screened. Thirty-six (6.2%) patients were on antibiotics and which were started at median of 7 days (inter-quartile rate (IQR), 4, 11) from symptom onset. Fifty-one antibiotics were prescribed in these patients. Overall, co-amoxiclav (26/51, 51.0%) was the most often prescribed antibiotic. Thirty-one out of 51 (60.8%) antibiotic prescriptions were appropriate. Among 20 inappropriate prescriptions, 18 (90.0%) were initiated in patients with low likelihood of bacterial infections. Antibiotic prescriptions were more appropriate when reviewed by infectious diseases physicians (13/31 [41.9%] versus 2/20 [10.0%], p = 0.015), and if reasons for use were stated in notes (31/31 [100.0%] versus 16/20 [80.0%], p = 0.019). CONCLUSIONS: Despite low prevalence of antibiotic use among confirmed and suspected COVID-19 patients at 2 centres in Singapore, there was significant proportion of inappropriate antibiotics use where bacterial infections were unlikely. AMS teams can tailor stewardship strategies using PPS results. The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy. 2021-03 2020-12-08 /pmc/articles/PMC7722492/ /pubmed/33307276 http://dx.doi.org/10.1016/j.jgar.2020.11.025 Text en © 2020 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Short Communication
Tan, Sock Hoon
Ng, Tat Ming
Tay, Hui Lin
Yap, Min Yi
Heng, Shi Thong
Loo, Audrey Yong Xin
Teng, Christine B.
Lee, Tau Hong
A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19)
title A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19)
title_full A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19)
title_fullStr A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19)
title_full_unstemmed A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19)
title_short A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19)
title_sort point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (covid-19)
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722492/
https://www.ncbi.nlm.nih.gov/pubmed/33307276
http://dx.doi.org/10.1016/j.jgar.2020.11.025
work_keys_str_mv AT tansockhoon apointprevalencesurveytoassessantibioticprescribinginpatientshospitalizedwithconfirmedandsuspectedcoronavirusdisease2019covid19
AT ngtatming apointprevalencesurveytoassessantibioticprescribinginpatientshospitalizedwithconfirmedandsuspectedcoronavirusdisease2019covid19
AT tayhuilin apointprevalencesurveytoassessantibioticprescribinginpatientshospitalizedwithconfirmedandsuspectedcoronavirusdisease2019covid19
AT yapminyi apointprevalencesurveytoassessantibioticprescribinginpatientshospitalizedwithconfirmedandsuspectedcoronavirusdisease2019covid19
AT hengshithong apointprevalencesurveytoassessantibioticprescribinginpatientshospitalizedwithconfirmedandsuspectedcoronavirusdisease2019covid19
AT looaudreyyongxin apointprevalencesurveytoassessantibioticprescribinginpatientshospitalizedwithconfirmedandsuspectedcoronavirusdisease2019covid19
AT tengchristineb apointprevalencesurveytoassessantibioticprescribinginpatientshospitalizedwithconfirmedandsuspectedcoronavirusdisease2019covid19
AT leetauhong apointprevalencesurveytoassessantibioticprescribinginpatientshospitalizedwithconfirmedandsuspectedcoronavirusdisease2019covid19
AT tansockhoon pointprevalencesurveytoassessantibioticprescribinginpatientshospitalizedwithconfirmedandsuspectedcoronavirusdisease2019covid19
AT ngtatming pointprevalencesurveytoassessantibioticprescribinginpatientshospitalizedwithconfirmedandsuspectedcoronavirusdisease2019covid19
AT tayhuilin pointprevalencesurveytoassessantibioticprescribinginpatientshospitalizedwithconfirmedandsuspectedcoronavirusdisease2019covid19
AT yapminyi pointprevalencesurveytoassessantibioticprescribinginpatientshospitalizedwithconfirmedandsuspectedcoronavirusdisease2019covid19
AT hengshithong pointprevalencesurveytoassessantibioticprescribinginpatientshospitalizedwithconfirmedandsuspectedcoronavirusdisease2019covid19
AT looaudreyyongxin pointprevalencesurveytoassessantibioticprescribinginpatientshospitalizedwithconfirmedandsuspectedcoronavirusdisease2019covid19
AT tengchristineb pointprevalencesurveytoassessantibioticprescribinginpatientshospitalizedwithconfirmedandsuspectedcoronavirusdisease2019covid19
AT leetauhong pointprevalencesurveytoassessantibioticprescribinginpatientshospitalizedwithconfirmedandsuspectedcoronavirusdisease2019covid19